by Ed Susman – Orlando, Florida – Researchers said they were surprised to find that prostate cancer patients treated with anticoagulants appear to achieve a longer median overall… read more.
As of 2009, the overall death rate for cancer in the United States had declined 20 percent from its peak in 1991, translating to the avoidance of approximately… read more.
Researchers have shown in the laboratory how a ‘transcription factor’ causes breast cancer cells to develop an aggressive subtype that lacks sensitivity to oestrogen and does not respond… read more.
Prostate cancer patients receiving the costly treatment known as proton radiotherapy experienced minimal relief from side effects such as incontinence and erectile dysfunction, compared to patients undergoing a… read more.
A new study comparing outcomes among prostate cancer patients treated with surgery versus radiotherapy found differences in urinary, bowel and sexual function after short-term follow-up, but those differences… read more.
Measurements taken over time of prostate specific antigen, the most commonly used screening test for prostate cancer in men, improve the accuracy of aggressive prostate cancer detection when… read more.
Magnetic resonance ultrasound fusion biopsy may aid in selection of patients for active surveillance versus aggressivetherapy, new study in The Journal of Urology® reports
There is no difference between proton radiotherapy (PRT) and intensity-modulated radiotherapy (IMRT) when comparing the toxicity among patients with prostate cancer at 12 months post-treatment according to a… read more.
by Bruce Sylvester – taken from The Lancet – Radiotherapy given immediately after prostate removal surgery has a long-term benefit of preventing progression of the disease, researchers reported… read more.
by Marybeth Burke – Continuous hormonal therapy is more effective than intermittent hormonal therapy for men with hormone-sensitive metastatic prostate cancer with minimal disease spread,
by Marybeth Burke – The investigational drug BMS-936558 caused tumour shrinkage in up to a quarter of patients with advanced melanoma, kidney and NSCLC cancers,
25 Feb 2012 – EAU Paris – Men often finds it difficult to talk with primary health specialists and this is certainly true in the case of BPH.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
